InSphero launches industry's first automation-compatible 3D human liver disease platform for NASH drug discovery and screening; 3D InSight(TM) Human Liver Disease platform provides the most physiologically relevant testing environment for efficacy and saf

Press/Media

Period17 Jul 2019

Media coverage

1

Media coverage

  • TitleInSphero launches industry's first automation-compatible 3D human liver disease platform for NASH drug discovery and screening; 3D InSight(TM) Human Liver Disease platform provides the most physiologically relevant testing environment for efficacy and saf
    Media name/outletPR Newswire
    Country/TerritoryUnited States
    Date17/07/19
    PersonsScott Friedman
View all 1
View less